NCT03460665 (EMBARGO) is a NA clinical trial of Arteriography in Knee Osteoarthritis, sponsored by Centre Hospitalier Universitaire de Nice.

Who is sponsoring NCT03460665?

NCT03460665 is sponsored by Centre Hospitalier Universitaire de Nice.

What drugs are being tested in NCT03460665?

Interventions in NCT03460665: Arteriography.

What condition does NCT03460665 study?

NCT03460665 studies Knee Osteoarthritis.

Is NCT03460665 still recruiting?

NCT03460665 is currently completed. Last updated 24 February 2025.

Last reviewed 2025-02-24 · How we verify

NCT03460665: EMBARGO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Symptomatic Efficacy of Microparticle Arterial Embolization in Knee Osteoarthritis Resistant to Medical Treatment

Completed NA Last updated 24 February 2025

What this trial tests

NA trial testing Arteriography in Knee Osteoarthritis in 18 participants. Completed in 29 January 2025.

Timeline

4 October 2018

Primary endpoint
4 October 2021

29 January 2025

Quick facts

Lead sponsor	Centre Hospitalier Universitaire de Nice
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	18
Start date	4 October 2018
Primary completion	4 October 2021
Estimated completion	29 January 2025
Sites	3 locations across France

Drugs / interventions tested

Arteriography

Conditions studied

Knee Osteoarthritis — all drugs for Knee Osteoarthritis →

Sponsor

Centre Hospitalier Universitaire de Nice

Who can join

Adults 40 to 80, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this double-blind, randomized, single-center prospective study (patient and evaluator) is to evaluate the efficacy of arterial occlusion (embolization) of neovessels by microparticle versus placebo on pain in disabling knee osteoarthritis at 12 months.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Transarterial Embolization for the Treatment of Chronic Musculoskeletal Pain: A Systematic Review of Indications, Safety, and Efficacy.
Kishore S, Sheira D, Malin ML, Trost DW, et al · · 2022 · cited 28× · PMID 34842365 · DOI 10.1002/acr2.11383

Verify or expand the search:

Other trials of Arteriography

Trials testing the same drug.

NCT05633134 — Precision Preoperative Embolization of Pelvic Tumors to Improve Surgical Outcomes · NA · unknown

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting

Other Centre Hospitalier Universitaire de Nice trials

Trials by the same sponsor.

NCT05897996 — Percutaneous Anastomosis Creation for Hemodialysis Access · NA · withdrawn
NCT07499869 — INNOVATIVE BENEFITS OF A 4D VIRTUAL SIMULATOR · NA · not yet recruiting
NCT07492251 — Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris: a Prospective Multicenter Ran · Phase 2 · not yet recruiting
NCT07511608 — Development of a New Technique for Quantifying Mitochondrial DNA in Single Muscle Fibers · NA · not yet recruiting
NCT07582406 — Codesign, Physical Activity, and Seniors · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03460665 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Nice
Last refreshed: 24 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03460665.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing